Skip to main content

Head & Neck Oncology

Ausgabe 1/2010

Inhalt (36 Artikel)

Open Access Review

Unicystic ameloblastoma of the mandible - an unusual case report and review of literature

Rakesh S Ramesh, Suraj Manjunath, Tanveer H Ustad, Saira Pais, K Shivakumar

Open Access Research

Paraganglioma of the endolarynx: a rare tumor in an uncommon location

Joseph R Smolarz, Ehab Y Hanna, Michelle D Williams, Michael E Kupferman

Open Access Case report

Rapid palliation of symptoms with platinum-based chemotherapy plus cetuximab in recurrent oral cancer: a case report

Ricard Mesía, Ramón Palmero, Mònica Cos, Esther Vilajosana, Silvia Vázquez

Open Access Review

Epithelial-myoepithelial carcinoma of the tongue base: a case for the case-report and review of the literature

Peter Peters, Costa Repanos, James Earnshaw, Patrick Stark, Bryan Burmeister, Lloyd McGuire, Susanne Jeavons, William B Coman AM

Open Access Research

Establishment and Characterization of a Novel Head and Neck Squamous Cell Carcinoma Cell Line USC-HN1

Daniel J Liebertz, Melissa G Lechner, Rizwan Masood, Uttam K Sinha, Jing Han, Raj K Puri, Adrian J Correa, Alan L Epstein

Open Access Research

Low prevalence of Human Papillomavirus in oral cavity carcinomas

Jerry Machado, Patricia P Reis, Tong Zhang, Colleen Simpson, Wei Xu, Bayardo Perez-Ordonez, David P Goldstein, Dale H Brown, Ralph W Gilbert, Patrick J Gullane, Jonathan C Irish, Suzanne Kamel-Reid

Open Access Review

Primary adenomyoepithelioma of tonsil

Juan Ren, Liping Song, Qiang Dang, Xiaozhi Zhang, Shi-Wen Jiang, Guanjun Zhang, Ning Wang, Zi Liu, Jiansheng Wang, Yi Lisa Hwa, Zongfang Li, Xinhan Zhao, Yuan Liu

Open Access Review

Molecular targeted therapies in head and neck cancer - An update of recent developements -

Martin Goerner, Tanguy Y Seiwert, Holger Sudhoff

Open Access Research

Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients

Waseem Jerjes, Tahwinder Upile, Aviva Petrie, Andrew Riskalla, Zaid Hamdoon, Michael Vourvachis, Kostas Karavidas, Amrita Jay, Ann Sandison, Gareth J Thomas, Nicholas Kalavrezos, Colin Hopper

Open Access Research

Evaluation of a low-cost, portable imaging system for early detection of oral cancer

Mohammed S Rahman, Nilesh Ingole, Darren Roblyer, Vanda Stepanek, Rebecca Richards-Kortum, Ann Gillenwater, Surendra Shastri, Pankaj Chaturvedi

Open Access Review

Management of Thyroid nodules in adult patients

Chee Yean Eng, Muhammad S Quraishi, Patrick J Bradley

Open Access Case report

Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine

Elad Sharon, Ronan J Kelly, Eva Szabo

Open Access Research

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)

Farshid Dayyani, Carol J Etzel, Mei Liu, Chung-Han Ho, Scott M Lippman, Anne S Tsao

Open Access Review

Skull base approaches in neurosurgery

Martin Scholz, Richard Parvin, Jost Thissen, Catharina Löhnert, Albrecht Harders, Klaus Blaeser

Open Access Erratum

Erratum to: Primary adenomyoepithelioma of tonsil

Juan Ren, Liping Song, Qiang Dang, Xiaozhi Zhang, Shi-Wen Jiang, Guanjun Zhang, Ning Wang, Zi Liu, Jiansheng Wang, Yi Lisa Hwa, Zongfang Li, Xinhan Zhao, Yuan Liu

Open Access Case report

Living related hemi-face skin transplant using radial forearm free flap for a xeroderma pigmentosa patient: early outcome

Ayman Amin, Mahmoud Bassiouny, Kareem Sallam, Galal Ghally, Hanaa El-Karaksy, Alaa El-Haddad

Open Access Research

FDG-PET staging and importance of lymph node SUV in head and neck cancer

Gregory J Kubicek, Collin Champ, Shannon Fogh, Fen Wang, Eashwer Reddy, Charles Intenzo, Reginald W Dusing, Mitchell Machtay

Open Access Research

Radiotherapy with or without chemotherapy for patients with T1-T2 glottic carcinoma: retrospective analysis

Naoki Hirasawa, Yoshiyuki Itoh, Shunichi Ishihara, Seiji Kubota, Junji Itoh, Yasushi Fujimoto, Tsutomu Nakashima, Shinji Naganawa

Open Access Research

C-reactive protein levels: a prognostic marker for patients with head and neck cancer?

Astrid L Kruse, Heinz T Luebbers, Klaus W Grätz

Open Access Research

Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database

Jean Lacau St Guily, Isabelle Borget, Alexandre Vainchtock, Vanessa Rémy, Claire Takizawa

Open Access Research

Malignant head and neck paragangliomas: Is there an optimal treatment strategy?

Daniel J Moskovic, Joseph R Smolarz, Douglas Stanley, Camilo Jimenez, Michelle D Williams, Ehab Y Hanna, Michael E Kupferman

Open Access Research

Oral squamous cell carcinoma in non-smoking and non-drinking patients

Astrid L Kruse, Marius Bredell, Klaus W Grätz

Open Access Research

Head and Neck Cancer in the Elderly: A Retrospective Study over 10 Years (1999 - 2008)

Astrid L Kruse, Marius Bredell, Heinz T Luebbers, Klaus W Grätz

Open Access Review

Raman spectroscopy in head and neck cancer

Andrew T Harris, Andrew Rennie, Haroon Waqar-Uddin, Sarah R Wheatley, Samit K Ghosh, Dominic P Martin-Hirsch, Sheila E Fisher, Alec S High, Jennifer Kirkham, Tahwinder Upile

Open Access Research

The chondroitin/dermatan sulfate synthesizing and modifying enzymes in laryngeal cancer: Expressional and epigenetic studies

Dimitrios Kalathas, Irene-Eva Triantaphyllidou, Nicholas S Mastronikolis, Panos D Goumas, Thoedore A Papadas, Gabriel Tsiropoulos, Demitrios H Vynios

Open Access Research

Electronic versus paper diaries: a pilot study of concordance and adherence in head and neck cancer patients receiving radiation therapy

Joseph M Blondin, Khamis S Abu-Hasaballah, Howard Tennen, Rajesh V Lalla

Open Access Research

Prognostic Significance of Nuclear Survivin Expression in Resected Adenoid Cystic Carcinoma of the Head and Neck

Yoon Ho Ko, Sang-Young Roh, Hye Sung Won, Eun Kyoung Jeon, Sook Hee Hong, Myung Ah Lee, Jin Hyoung Kang, Young Seon Hong, Min Sik Kim, Chan-Kwon Jung

Open Access Research

Patient reported outcomes in head and neck cancer: selecting instruments for quality of life integration in clinical protocols

Augusta P Silveira, Joaquim Gonçalves, Teresa Sequeira, Cláudia Ribeiro, Carlos Lopes, Eurico Monteiro, Francisco L Pimentel

Open Access Research

Immunohistochemical analysis of undifferentiated and poorly-differentiated head and neck malignancies at a tertiary hospital in Nigeria

Akinyele O Adisa, Abideen O Oluwasola, Bukola F Adeyemi, Bamidele Kolude, Effiong EU Akang, Jonathan O Lawoyin

Open Access Research

Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience

Alexandra D Jensen, Zazie P Bergmann, Helena Garcia-Huttenlocher, Kolja Freier, Jürgen Debus, Marc W Münter

Open Access Research

Combined magnetic resonance and optical imaging of head and neck tumor xenografts using Gadolinium-labelled phosphorescent polymeric nanomicelles

Rajiv Kumar, Tymish Y Ohulchanskyy, Steve G Turowski, Mark E Thompson, Mukund Seshadri, Paras N Prasad

Open Access Research

p53 in head and neck cancer: Functional consequences and environmental implications of TP53mutations

Jenni K Peltonen, Henni M Helppi, Paavo Pääkkö, Taina Turpeenniemi-Hujanen, Kirsi H Vähäkangas

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.